NO20000469L - Legemiddel for skallethet og andre sykdommer - Google Patents

Legemiddel for skallethet og andre sykdommer

Info

Publication number
NO20000469L
NO20000469L NO20000469A NO20000469A NO20000469L NO 20000469 L NO20000469 L NO 20000469L NO 20000469 A NO20000469 A NO 20000469A NO 20000469 A NO20000469 A NO 20000469A NO 20000469 L NO20000469 L NO 20000469L
Authority
NO
Norway
Prior art keywords
baldness
medication
diseases
seborrhea
alopecia
Prior art date
Application number
NO20000469A
Other languages
English (en)
Other versions
NO20000469D0 (no
Inventor
Koichi Kojima
Takakazu Hamada
Shiroh Yoshioka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20000469D0 publication Critical patent/NO20000469D0/no
Publication of NO20000469L publication Critical patent/NO20000469L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20000469A 1997-07-29 2000-01-28 Legemiddel for skallethet og andre sykdommer NO20000469L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29
PCT/JP1998/003337 WO1999006050A1 (fr) 1997-07-29 1998-07-27 Agent reparateur contre la calvitie et autres maladies

Publications (2)

Publication Number Publication Date
NO20000469D0 NO20000469D0 (no) 2000-01-28
NO20000469L true NO20000469L (no) 2000-03-28

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000469A NO20000469L (no) 1997-07-29 2000-01-28 Legemiddel for skallethet og andre sykdommer

Country Status (22)

Country Link
US (1) US6380179B1 (no)
EP (1) EP0998930B1 (no)
KR (1) KR20010022066A (no)
CN (1) CN1129433C (no)
AT (1) ATE262337T1 (no)
AU (1) AU733830B2 (no)
BR (1) BR9811293A (no)
CA (1) CA2298851A1 (no)
DE (1) DE69822636T2 (no)
DK (1) DK0998930T3 (no)
ES (1) ES2218840T3 (no)
HK (1) HK1027290A1 (no)
HU (1) HUP0003159A3 (no)
ID (1) ID24566A (no)
IL (1) IL134199A0 (no)
NO (1) NO20000469L (no)
NZ (1) NZ502537A (no)
PL (1) PL338414A1 (no)
PT (1) PT998930E (no)
RU (1) RU2193887C2 (no)
TR (1) TR200000263T2 (no)
WO (1) WO1999006050A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20120245205A1 (en) 2009-07-29 2012-09-27 Delong Mitchell A Compositions and methods for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 4−アザステロイド化合物
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
AU7078296A (en) 1995-09-27 1997-04-17 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
NZ326897A (en) * 1996-02-05 1999-08-30 Sankyo Co 5 <alpha>-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma

Also Published As

Publication number Publication date
WO1999006050A1 (fr) 1999-02-11
TR200000263T2 (tr) 2000-09-21
ID24566A (id) 2000-07-27
CN1129433C (zh) 2003-12-03
PT998930E (pt) 2004-05-31
CA2298851A1 (en) 1999-02-11
HUP0003159A3 (en) 2001-07-30
HUP0003159A2 (hu) 2001-04-28
IL134199A0 (en) 2001-04-30
BR9811293A (pt) 2000-08-29
AU8358598A (en) 1999-02-22
ATE262337T1 (de) 2004-04-15
AU733830B2 (en) 2001-05-24
DE69822636T2 (de) 2005-01-05
DK0998930T3 (da) 2004-04-26
US6380179B1 (en) 2002-04-30
PL338414A1 (en) 2000-11-06
DE69822636D1 (de) 2004-04-29
EP0998930A1 (en) 2000-05-10
NO20000469D0 (no) 2000-01-28
CN1271285A (zh) 2000-10-25
EP0998930A4 (en) 2002-06-12
ES2218840T3 (es) 2004-11-16
HK1027290A1 (en) 2001-01-12
KR20010022066A (ko) 2001-03-15
EP0998930B1 (en) 2004-03-24
NZ502537A (en) 2002-11-26
RU2193887C2 (ru) 2002-12-10

Similar Documents

Publication Publication Date Title
HK1046639A1 (en) Nitroimidazole external preparations for dermatosis
BR9807674A (pt) Inibidores bicìclicos da proteìna farnesil transferase
DE69608904D1 (de) Nicht-steroidale sulfatase hemmer verbindungen
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
DE69329149T2 (de) 4-azasteroide als 5-alpha-reduktase
MX9800718A (es) Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida.
PT918776E (pt) Sintese total de acilfulvenos antitumorais
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
NO20000469D0 (no) Legemiddel for skallethet og andre sykdommer
AU681021B2 (en) Indole derivative and medicine containing the same
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
ES2064347T3 (es) Un proceso para la preparacion de un derivado de cinamoilamida.
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
TH10003EX (th) อนุพันธ์โคลแมนและไธโอโคลแมนชนิดใหม่

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application